You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 5,591,605


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,591,605
Title: Plant structural gene expression
Abstract:The invention provides genetically modified plant cells having a plant structural gene introduced and expressed therein under the control of a T-DNA promoter. In particular, the invention provides genetically modified plant cells having the phaseolin gene introduced and expressed therein under the control of a T-DNA promoter. Also provided are novel strains of bacteria containing and replicating T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter. Further, the invention provides novel plasmids having the ability to replicate in E. coli and comprising T-DNA which has been modified to contain an inserted plant structural gene under the control of a T-DNA promoter.
Inventor(s): Hall; Timothy C. (College Station, TX), Kemp; John D. (Las Cruces, NM), Slightom; Jerry L. (Kalamazoo, MI), Sutton; Dennis W. (Las Cruces, NM)
Assignee: Mycogen Plant Science, Inc. (San Diego, CA)
Application Number:08/296,073
Patent Claims:1. A plant comprising a genetically modified dicot plant cell, which dicot plant cell comprises T-DNA sequences flanking a plant structural gene, which gene is expressed in said plant under the control of a T-DNA promoter, wherein said dicot plant cell comprises T-DNA wherein the tms locus or the tmr locus, or both of said loci, have been inactivated.

2. A plant according to claim 1 wherein the plant structural gene comprises an intron.

3. A plant according to claim 1 wherein the plant structural gene is under control of a promoter selected from the group of T-DNA genes consisting of tmr, tml, tms, nopaline synthase, octopine synthase, and the 1.6 transcript.

4. A plant according to claim 1 wherein the plant structural gene is modified.

5. A plant according to claim 4 wherein the plant structural gene modification comprises removal of an intron.

6. A plant according to claim 4 wherein the plant structural gene comprises cDNA.

7. A plant according to claim 4 wherein the plant structural gene modification comprises a DNA segment insertion.

8. A plant according to claim 4 wherein the plant structural gene modification comprises a DNA segment deletion.

9. A plant according to claim 1 wherein the T-DNA is modified.

10. A plant according to claim 9 wherein the T-DNA modification comprises a mutation in tms.

11. A plant according to claim 9 wherein the modification comprises a mutation in tmr.

12. A plant according to claim 9 wherein the modification comprises a deletion in T-DNA.

13. A plant according to claim 1 wherein the T-DNA promoter includes part of the coding region of the T-DNA gene normally controlled by said promoter.

14. A plant according to claim 13 wherein the plant structural gene comprises an intron.

15. A plant according to claim 13 wherein the plant structural gene codes for phaseolin.

16. A plant according to claim 15 wherein the phaseolin gene is inserted under control of a promoter selected from the group of T-DNA genes consisting of tmr, tml, tms, nopaline synthase, octopine synthase, and the 1.6 transcript.

17. A plant according to claim 16 wherein the plant is a member of the family Compositeae.

18. A plant according to claim 16 wherein the plant is a member of the family Solanaceae.

19. A plant according to claim 16 wherein the plant is a member of the family Leguminoseae.

20. Plant tissue comprising a genetically modified dicot plant cell, which dicot plant cell comprises T-DNA sequences flanking a plant structural gene, which gene is expressed in said plant under the control of a T-DNA promoter, wherein said dicot plant cell comprises T-DNA wherein the tms locus or the tmr locus, or both of said loci, have been inactivated.

21. Plant tissue according to claim 20 wherein the inserted plant structural gene comprises an intron.

22. Plant tissue according to claim 20 wherein the plant structural gene is under control of a promoter selected from the group of T-DNA genes consisting of tmr, tml, tms, nopaline synthase, octopine synthase, and the 1.6 transcript.

23. Plant tissue according to claim 20 wherein the plant structural gene is modified.

24. Plant tissue according to claim 23 wherein the plant structural gene modification comprises removal of an intron.

25. Plant tissue according to claim 23 wherein the plant structural gene comprises cDNA.

26. Plant tissue according to claim 23 wherein the plant structural gene modification comprises a DNA segment insertion.

27. Plant tissue according to claim 23 wherein the plant structural gene modification comprises a DNA segment deletion.

28. Plant tissue according to claim 20 wherein the T-DNA is modified.

29. Plant tissue according to claim 28 wherein the T-DNA modification comprises a mutation in tms.

30. Plant tissue according to claim 28 wherein the T-DNA modification comprises a mutation in tmr.

31. Plant tissue according to claim 28 wherein the T-DNA modification comprises a deletion in T-DNA.

32. Plant tissue according to claim 20 wherein the T-DNA promoter includes part of the coding region of the T-DNA gene normally controlled by said promoter.

33. Plant tissue according to claim 32 wherein the inserted plant structural gene comprises an intron.

34. Plant tissue according to claim 32 wherein the plant structural gene is the gene for phaseolin.

35. Plant tissue according to claim 34 wherein the phaseolin gene is inserted under control of a promoter selected from the group of T-DNA genes consisting of tmr, tml, tms, nopaline synthase, octopine synthase, and the 1.6 transcript.

36. Plant tissue according to claim 35 wherein the plant cell is derived from a member of the family Compositeae.

37. Plant tissue according to claim 35 wherein the plant cell is derived from a member of the family Solanaceae.

38. Plant tissue according to claim 35 wherein the plant cell is derived from a member of the family Leguminoseae.

39. A method for genetically modifying a dicot plant cell, said method comprising:

(a) providing a DNA vector, said vector comprising Ti plasmid-derived DNA integration functions, and farther comprising a plant structural gene and a T-DNA promoter, said T-DNA promoter and said plant structural gene being in such position and orientation with respect to each other that said plant structural gene is expressible in said plant cell under the control of said T-DNA promoter, and wherein said vector comprises a T-DNA fragment wherein the tms locus or the tmr locus, or both of said loci, have been inactivated; and

(b) transferring said DNA vector into a dicot plant cell under conditions so that said plant cell is transformed.

40. The method of claim 39 wherein said plant structural gene contains at least one intron.

41. The method of claim 39 wherein said plant structural gene comprises a modified DNA sequence of the naturally-occurring form of a plant structural gene.

42. The method of claim 41 wherein said modification comprises the removal of an intron.

43. The method of claim 41 wherein said plant structural gene comprises cDNA.

44. The method of claim 39 wherein said T-DNA is modified.

45. The method of claim 44 wherein said T-DNA modification comprises a mutation in tms.

46. The method of claim 44 wherein the T-DNA modification comprises a mutation in tmr.

47. The method of claim 39 wherein said T-DNA promoter is a promoter that controls a T-DNA gene selected from the group consisting of tmr, tml, tms, nopaline synthase, octopine synthase, and the 1.6 transcript.

48. The method of claim 47 wherein said T-DNA gene is nopaline synthase.

49. The method of claim 47 wherein said T-DNA gene is octopine synthase.

50. The method of claim 47 wherein said T-DNA gene is the 1.6 transcript.

51. The method of claim 39 wherein said plant structural gene is fused to a T-DNA structural gene under the control of said T-DNA promoter.

52. A dicot plant regenerated from a genetically modified, regenerable dicot plane cell, which plant cell comprises T-DNA sequences flanking a plant structural gene, which gene is expressed in said plant under the control of a T-DNA promoter, wherein said dicot plant cell comprises T-DNA wherein the tms locus or the tmr locus, or both of said loci, have been inactivated.

53. A method for expression of a plant structural gene in a plant, said method comprising:

(a) genetically modifying a dicot plant cell by providing a T-DNA vector, said vector comprising Ti-plasmid-derived DNA integrations functions, and further comprising a plant structural gene and a T-DNA promoter, said T-DNA promoter and said plant structural gene being in such position and orientation with respect to each other that said plant structural gene is expressible in a dicot plant cell under the control of said T-DNA promoter, and wherein said vector comprises a T-DNA fragment wherein the tms locus or the tmr locus, or both of said loci, have been inactivated; and transferring the T-DNA vector into the dicot plant cell under conditions so that said plant cell is transformed; and

(b) regenerating said transformed plant cell to a whole plant wherein said plant structural gene is expressed under the control of said T-DNA promoter.

54. A method for expressing a plant structural gene in a plant tissue, said method comprising:

(a) genetically modifying a dicot plant cell by providing a T-DNA vector, said vector comprising T-DNA Ti-plasmid-derived DNA integration functions, and further comprising a plant structural gong and a T-DNA promoter, said T-DNA promoter and said plant structural gene being in such position and orientation with respect to each other that said plant structural gene is expressible in a plant cell under the control eft said T-DNA promoter, and wherein said vector comprises a T-DNA fragment wherein the tms locus or the tmr locus, or both of said loci, have been inactivated; and

(b) allowing proliferation of said transformed plant cell into plant tissue wherein said structural gene is expressed under control of said T-DNA promoter.

55. A transformed whole dicot plant selected from the group consisting of a dicot plant regenerated from a dicot cell transformed to express a heterologous plant structural gene under the control of a T-DNA promoter, said cell containing T-DNA wherein the tms locus or the tmr locus, or both of said loci, have been inactivated; and progeny of said plant.

56. Plant tissue comprising a dicot cell transformed to express a heterologous plant structural gene under the control of a T-DNA promoter, said cell containing T-DNA wherein the tins locus or the tmr locus, or both of said loci have been inactivated.

57. Tissue according to claim 56, wherein said plant tissue is a seed.

58. A method for expressing a plant structural gene in plant tissue, said method comprising providing a dicot cell transformed to express a heterologous plant structural gene under the control of a T-DNA promoter, said cell containing T-DNA wherein the tms locus or the tmr locus, or both of said loci, have been inactivated; and maintaining said cell in conditions where said cell proliferates and said plant structural gene is expressed.

Details for Patent 5,591,605

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2014-01-07
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2014-01-07
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2014-01-07
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.